The Testosterone Prescription Lie

The Testosterone Prescription Lie

Guys, I'm really pissed off. I'm sure you'll be once you finish reading this post about how drug companies are selling prescription testosterone to men just like you that could increase their testosterone naturally more safely and effectively.

Drug companies have been been deceptively promoting dangerous and unnecessary testosterone prescriptions to millions of men, making BILLIONS each year and exposing countless men to potentially dangerous side effects. A recent article in the the Journal of the American Geriatrics Society calls for a ban of direct-to-consumer product advertising (DTCPA) of prescription testosterone products which has led to:

10- and 40-fold increases in testosterone prescriptions in the United States and Canada, respectively, with Internet pharmacies playing a major role in the latter's increase. U.S. pharmaceutical sales of testosterone increased from $324 million in 2002 to $2 billion in 2012, and the number of testosterone doses prescribed climbed from 100 million in 2007 to half a billion in 2012, not including the additional contributions from compounding pharmacies, Internet, and direct-to-patient clinic sales.

Do you think drug companies want you to learn how to raise your testosterone naturally?

Testosterone Prescription Sales

Testosterone Prescription Sales from Repros Therapeutics Inc., Form 8-K November 13, 2012

Furthermore, the detrimental effect of DTCPA has been magnified by lax prescribing guidelines, which are used by doctors to determine whether a patients should be prescribed testosterone or not.

Guidelines created over the last decade, some sponsored by manufacturers of testosterone products, have stretched the definition of hypogonadism, a clinical disorder of the hypothalamus–pituitary–testicular axis that has a pathological basis, to include functional disorders so as to include men with an unexplained low serum testosterone level (without any underlying reproductive pathology) accompanied by complaints that are commonly associated with classical hypogonadism but also many age-related comorbidities. Marketers of "low T" have capitalized upon the nonspecificity of these age-related symptoms by encouraging men to take questionnaires of equally low specificity focusing on common complaints such as low energy, feeling sad, sleep problems, decreased physical performance, or increased fat. Notably, in middle-aged and older men who report excellent health, aging is not associated with a decrease in serum testosterone, highlighting the effect of age-associated comorbidities rather than age itself upon testosterone levels.

Basically, drug companies are selling prescription testosterone to men that DO NOT NEED IT.  These are men whose low testosterone is caused by "comorbidities." These comorbidities  are exactly the issues that Testosterone Answers is designed to help you address.

Even the U.S. Food and Drug Administration (FDA) which approved these prescription testosterones is taking notice; last year convening a meeting "to address concerns that many men are receiving testosterone who should not and because of reports of adverse cardiovascular events in men using testosterone."

The authors of the article "characterize the mass marketing of testosterone coupled with the permissive prescribing of testosterone for common, nonspecific, aging-related symptoms as disease mongering of declines in testosterone with advancing age. Disease mongering is defined as "the selling of sickness that widens the boundaries of illness and grows the markets for those who sell and deliver treatments."

Pissed off yet? Let's take back our testosterone. 



Perls, Thomas, and David J. Handelsman. “Disease Mongering of Age-Associated Declines in Testosterone and Growth Hormone Levels.” Journal of the American Geriatrics Society, March 1, 2015, n/a – n/a. doi:10.1111/jgs.13391. (Full text)


Comments are closed.